Strattera (atomoxetine) is a nonstimulant norepinephrine reuptake inhibitor used for attention-deficit/hyperactivity disorder in selected children, adolescents and adults, with treatment monitored for mood changes, blood pressure, pulse, liver symptoms and gradual changes in functioning.
Key Takeaways
- Atomoxetine is not a stimulant and is used to treat ADHD in selected patients.
- The list includes 24 offers with totals from $33.99 to $575.99 USD.
- A U.S. boxed warning addresses suicidal ideation risk in children and adolescents.
- Blood pressure, pulse and uncommon liver problems are monitoring concerns.
- Capsules should be swallowed whole rather than opened for dose adjustment.
Strattera: General Information
Atomoxetine is sometimes selected when a clinician wants a nonstimulant option for ADHD, but the term nonstimulant should not be mistaken for risk-free. The treatment aims to improve attention and reduce impulsivity or hyperactivity as part of a broader plan that may include behavioral support, school accommodations or adult workplace strategies. Its effect is normally evaluated over weeks. Families should be prepared to discuss not only school grades or task completion but also irritability, sleep, appetite and any unexpected deterioration in mood.
Time to Evaluate Response
The first days of atomoxetine treatment may bring adverse effects before the therapeutic benefit is fully apparent. Clinicians usually evaluate response across weeks, with adjustments guided by the patient’s age, weight when relevant, other medicines and tolerability.
Stopping after one unremarkable day or rapidly increasing the dose can give a misleading picture of effectiveness. A follow-up plan should identify what improvement would count as meaningful and what adverse effects would require a call to the prescriber.
The catalog lists 10 mg, 18 mg, 25 mg and 40 mg options. These strengths are not a step-by-step dosing instruction, and the correct regimen should be taken from the prescription.
Some patients require different titration because of interactions involving CYP2D6 metabolism or other medical considerations. Capsules should generally be swallowed intact according to the product label, and their contents should not be handled casually because exposure can irritate the eyes.
Atomoxetine and ADHD
The U.S. atomoxetine label carries a warning about increased suicidal thinking in children and adolescents in short-term clinical trials. That warning calls for careful observation at the start of therapy and during dose changes. Blood pressure and heart rate can also increase, while rare liver injury has been reported. These concerns are not reasons to make an automatic decision about every patient, but they are reasons that prescription follow-up and communication between the family and clinician cannot be replaced by an online refill.
Strattera is a trade name for atomoxetine, a nonstimulant medicine prescribed for attention-deficit/hyperactivity disorder in appropriate patients. ADHD may involve persistent inattention, difficulties organizing work, impulsivity or excessive activity that causes impairment in more than one setting. Diagnosis requires an evaluation of the duration and context of symptoms, developmental history and other conditions that can resemble ADHD. A medicine should not be selected solely because a person struggles to concentrate during a stressful period.
Atomoxetine inhibits norepinephrine reuptake and differs from stimulant medicines that act more directly on dopaminergic and noradrenergic signaling. Its effect generally develops over time rather than producing a dramatic immediate change after the first capsule. Families and adult patients often benefit from agreed measures of progress, including ability to complete work, manage transitions, control impulsivity and participate consistently at home or school. Medication may be combined with education, behavioral strategies and support for executive functioning.
Mood and Suicidality Warning
Atomoxetine carries a warning about increased suicidal thinking in children and adolescents, particularly early in treatment or after a dose change. Families should watch for new agitation, marked mood changes, worsening depression or statements about self-harm and contact the treating clinician promptly.
Adults also need monitoring for new psychiatric symptoms, although the formal boxed warning focuses on pediatric patients. A diagnosis of ADHD does not exclude anxiety, depression, bipolar disorder or other conditions that may need their own assessment.
Unusual aggression, hallucinations or pronounced mood elevation should prompt medical review. A child who becomes quiet or withdrawn after starting treatment has not necessarily become healthier simply because classroom disruption decreases.
The aim is improved functioning and well-being, not suppression of personality. Caregivers and teachers can contribute useful observations when they describe specific behavioral changes instead of giving only a general judgment that the medicine is working.
School, Work and Daily Skills
Medication can support attention and impulse control but does not teach organizational skills automatically. Many patients benefit from structured calendars, reduced distraction, sleep routines and realistic workload planning. For children, coordination among caregivers, teachers and the treating clinician can make it easier to understand whether improvement is consistent across settings. For adults, measuring missed deadlines, task initiation and relationship difficulties can be more useful than relying on a vague sense of productivity.
ADHD often continues across life stages, so the need for treatment may change with school demands, employment, coexisting conditions and personal preference. Regular review can assess whether the current regimen remains suitable, whether behavioral support is sufficient, or whether another medication would better meet the patient’s needs. An internet pharmacy should supply the requested medicine only when the prescription and patient circumstances have been appropriately reviewed, not decide that anyone reporting poor concentration needs atomoxetine.
During the first weeks, families and adults can agree on observable markers of change rather than relying solely on a subjective impression. Work completion, sustained attention, sleep quality, appetite and unexpected mood symptoms can all be discussed at follow-up.
Cardiovascular and Liver Precautions
Atomoxetine can increase heart rate and blood pressure in some patients, so the prescriber may review personal and family cardiac history and arrange measurements during follow-up. Chest pain, fainting or concerning palpitations require evaluation.
Rare serious liver injury has been reported, and new jaundice, dark urine or unexplained severe itching should be reported immediately. Medication review is also important because certain antidepressants can raise atomoxetine exposure through metabolic interactions.
Common adverse effects can include reduced appetite, abdominal discomfort, nausea, sleep changes and dry mouth. In younger patients, weight and growth should be monitored over time.
A treatment that improves attention but creates significant weight loss or sleep disruption needs reconsideration. The prescriber may assess whether taking the medicine at a different time or adjusting the regimen is appropriate, while the patient should avoid improvised changes to capsules or dose.
Price Options
Mexican Pharmacy King lists 24 selectable options for Strattera Generic (Atomoxetine). The amounts shown below are the listed USD totals for several different strengths and quantities, not a prediction of what an unrelated pharmacy in Mexico will charge. Across the available combinations, the smallest listed total is $33.99 USD and the largest is $575.99 USD. These figures need to be checked again at ordering because availability, product specifications and final charges can change.
| Option | Quantity | Listed total |
|---|---|---|
| 10 mg | 30 pills | $40.99 USD |
| 18 mg | 10 pills | $33.99 USD |
| 18 mg | 360 pills | $575.99 USD |
| 25 mg | 90 pills | $190.99 USD |
| 40 mg | 30 pills | $118.99 USD |
Strattera options cover a wide range of strengths and quantities. A lower milligram strength is not necessarily a cheaper treatment course once the prescribed schedule is considered, because patients may use different numbers of capsules. Capsules should not be opened to approximate an unavailable strength. Before ordering, confirm the actual dose, the planned review date and whether the patient is transitioning from another ADHD medicine. Large supplies are most appropriate only after the regimen has been stabilized.
An option displayed at a lower total may contain fewer units, while an apparently expensive offer may cover several treatment periods. The table is intended to explain the listed choices and is not an instruction to extend treatment. If the clinician changes the prescription, verify the available alternatives and the total again rather than selecting from an earlier screenshot or a saved cart.
Ordering from Mexico
Pharmaceutical registration in Mexico is handled by COFEPRIS, which publishes a public register of authorized medicines. A name in a retail catalog does not by itself prove that a particular brand, batch or supplier is licensed, so the registration and the identifying details of the dispensed product should be checked independently. This also means that a medicine sold lawfully in Mexico is not automatically eligible for entry into another country. The applicable U.S. import rules and any prescription requirements must be confirmed before an international order is placed.
Safety Information
A qualified prescriber should reconcile allergies, chronic conditions and every current medication before treatment begins. If severe adverse symptoms develop, the appropriate response is medical assessment rather than trying another quantity or relying on an online product comparison. This page provides general medicine information, not an individualized dosing schedule or permission to substitute one registered product for another.
Strattera Questions
How quickly does atomoxetine work? Some changes may appear early, but fuller assessment commonly takes several weeks; the clinician sets follow-up based on response and tolerability.
Is Strattera a stimulant? No. Atomoxetine is a selective norepinephrine reuptake inhibitor, though it still requires careful monitoring.
Why is mood monitoring emphasized? The U.S. label warns of increased suicidal ideation in children and adolescents in short-term studies.
Can capsules be opened and mixed with food? They should be swallowed whole; follow the product instructions and seek another formulation if swallowing is a problem.
Does it replace educational support? Medication is generally one part of a treatment program rather than a substitute for tailored behavioral and educational strategies.
Why are prices different at the same count? Different strengths can have different totals, so compare like-for-like doses and quantities.
Clinical References
For product labeling, regulatory details and current patient guidance, consult MedlinePlus: Atomoxetine and the COFEPRIS medicine registration lists. These resources should be read together with the instructions supplied by the licensed prescriber and the label for the dispensed product.





